DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $27.00

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) had its price objective reduced by analysts at Evercore ISI from $28.00 to $27.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s price objective points to a potential upside of 10.61% from the company’s previous close.

XRAY has been the topic of a number of other reports. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Piper Sandler restated a “neutral” rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Finally, The Goldman Sachs Group lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Monday, May 6th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $34.33.

View Our Latest Research Report on XRAY

DENTSPLY SIRONA Trading Up 0.9 %

Shares of XRAY opened at $24.41 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 1-year low of $23.94 and a 1-year high of $41.65. The stock has a market capitalization of $5.07 billion, a P/E ratio of -55.48, a P/E/G ratio of 1.10 and a beta of 1.01. The business’s 50-day moving average price is $26.77 and its 200 day moving average price is $31.17.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same period last year, the firm posted $0.39 earnings per share. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year. Analysts expect that DENTSPLY SIRONA will post 2.02 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Gregory T. Lucier bought 3,577 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the purchase, the director now owns 58,374 shares in the company, valued at $1,631,553.30. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of XRAY. Royal London Asset Management Ltd. lifted its stake in DENTSPLY SIRONA by 1.6% during the third quarter. Royal London Asset Management Ltd. now owns 88,725 shares of the medical instruments supplier’s stock worth $3,031,000 after purchasing an additional 1,360 shares during the period. GSA Capital Partners LLP acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at $812,000. Graham Capital Management L.P. raised its holdings in shares of DENTSPLY SIRONA by 21.1% in the third quarter. Graham Capital Management L.P. now owns 30,753 shares of the medical instruments supplier’s stock valued at $1,051,000 after buying an additional 5,366 shares during the last quarter. Deutsche Bank AG lifted its position in DENTSPLY SIRONA by 12.0% during the 3rd quarter. Deutsche Bank AG now owns 771,684 shares of the medical instruments supplier’s stock worth $26,361,000 after buying an additional 82,840 shares in the last quarter. Finally, VisionPoint Advisory Group LLC grew its holdings in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.